This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,601 Years Active: 2016
Title: Nepton Soltani: Innovator in Diabetes Treatment
Introduction
Nepton Soltani is a notable inventor based in Bandar Abbas, Iran. He has made significant contributions to the field of diabetes treatment through his innovative research and development.
Latest Patents
Nepton Soltani holds a patent for a pharmaceutical composition aimed at the treatment of type-1 diabetes. This composition includes a GABAergic and incretin, exemplified by GABA and GLP-1/Ex4. The formulation is designed to promote beta-cell regeneration, prevent beta-cell apoptosis, and control autoimmunity, thereby aiding in the prevention and treatment of type-1 diabetes in mammals. He has 1 patent to his name.
Career Highlights
Throughout his career, Nepton Soltani has focused on advancing medical treatments, particularly in the area of diabetes. His work has the potential to significantly improve the quality of life for individuals suffering from this chronic condition.
Collaborations
Nepton Soltani collaborates with fellow researcher Qinghua Wang, contributing to the advancement of their shared goals in medical innovation.
Conclusion
Nepton Soltani's contributions to diabetes treatment through his patented pharmaceutical composition highlight his role as an important figure in medical research. His work continues to pave the way for future advancements in the treatment of type-1 diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile